Serum neurofilaments as a potential biomarker of disability and cognitive decline in patients with multiple sclerosis

被引:0
|
作者
Yanakieva, Magdalina [1 ]
Ovcharova, Emilia [1 ]
Danovska, Maya [1 ]
Marinova-Trifonova, Diana [1 ]
Atanasova, Milena [2 ]
机构
[1] UMHAT Dr Georgi Stranski Med Univ Pleven, Neurol Clin, Pleven, Bulgaria
[2] Med Univ Pleven, Pleven, Bulgaria
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1546/1103
引用
收藏
页码:980 / 981
页数:2
相关论文
共 50 条
  • [31] High fidelity fixational eye movements as a novel potential biomarker for disability in multiple sclerosis
    Sheehy, C. K.
    Bensinger, E.
    Romeo, A.
    Rani, L.
    Shi, B.
    Gelfand, J. M.
    Stevenson, S. B.
    Green, A. J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 572 - 573
  • [32] APOE ε4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis
    Shi, Jiong
    Tu, Jiang-Long
    Gale, Shawn D.
    Baxter, Leslie
    Vollmer, Timothy L.
    Campagnolo, Denise I.
    Tyry, Tuula M.
    Zhuang, Yi
    Kuniyoshi, Sandra M.
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2011, 24 (03) : 128 - 133
  • [33] Hippocampal atrophy does not correlate with cognitive decline in patients with multiple sclerosis
    Benedict, R.
    Ramasamy, D. R.
    Cox, J. L.
    Dwyer, M. G.
    Fritz, D.
    Munschauer, F. E.
    Weinstock-Guttman, B.
    Zivadinov, R.
    JOURNAL OF NEUROLOGY, 2007, 254 : 14 - 14
  • [34] Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis
    Koraysha, Noha Abo
    Kishk, Nirmeen
    Hassan, Amr
    El Gendy, Nehal M. Samy
    Shehata, Hatem S.
    Al-Azayem, Salsabil Abo
    Karnal, Yasmine Shawki
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2571 - 2578
  • [35] Age of onset effect on cognitive disability progression in multiple sclerosis patients
    De Meo, E.
    Portaccio, E.
    Giorgio, A.
    Ruano, L.
    Goretti, B.
    Niccolai, C.
    Patti, F.
    Chisari, C.
    Gallo, P.
    Grossi, P.
    Ghezzi, A.
    Roscio, M.
    Mattioli, F.
    Stampatori, C.
    Simone, M.
    Viterbo, R.
    De Stefano, N.
    Inglese, M.
    Filippi, M.
    Amato, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 144 - 144
  • [36] Prevalence of cognitive impairment in a multiple sclerosis patients cohort with low disability
    Meca-Lallana, J. E.
    Jimenez-Veiga, J.
    Valero-Lopez, G.
    Millan-Pascual, J.
    Jimenez-Martin, I.
    Sistiaga-Berrondo, A.
    Carles-Dies, R.
    Costa-Arpin, E.
    Castillo-Trivino, T.
    Croitoru, I.
    Iniesta-Martinez, F.
    Carreon-Guarnizo, E.
    Olascoaga-Urtaza, J.
    Prieto-Gonzalez, J. M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 191 - 191
  • [37] Effects of mitoxantrone treatment on cognitive and physical disability in patients with multiple sclerosis
    Ozakbas, Serkan
    Idiman, Egemen
    Kaya, Derya
    Poyraz, Turan
    Poyraz, Esra Coskuner
    NEUROLOGY, 2008, 70 (11) : A95 - A95
  • [38] Cognitive function predicts work disability among multiple sclerosis patients
    Kavaliunas, Andrius
    Tinghog, Petter
    Friberg, Emilie
    Olsson, Tomas
    Alexanderson, Kristina
    Hillert, Jan
    Karrenbauer, Virginija Danylaite
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (01)
  • [39] Cognitive function predicts work disability among multiple sclerosis patients
    Kavaliunas, A.
    Karrenbauer, V. Danylaite
    Tinghog, P.
    Friberg, E.
    Olsson, T.
    Alexanderson, K.
    Hillert, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 479 - 480
  • [40] Cerebrospinal fluid amyloid-β as potential biomarker for cognitive functioning in multiple sclerosis
    Van Dam, M.
    Willemse, E.
    Nauta, I.
    Huiskamp, M.
    Klein, M.
    Moraal, B.
    Geurts, J.
    Uitdehaag, B.
    Teunissen, C.
    De Jong, B.
    Hulst, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 495 - 496